Logotype for LB Pharmaceuticals Inc

LB Pharmaceuticals (LBRX) investor relations material

LB Pharmaceuticals Corporate Presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for LB Pharmaceuticals Inc
Corporate Presentation summary18 Sep, 2025

Clinical development and pipeline

  • Advancing LB-102, a novel derivative of amisulpride, for neuropsychiatric disorders including schizophrenia (SCZ), bipolar depression (BPD), and major depressive disorder (MDD).

  • Phase 2 SCZ trial showed statistically significant benefit versus placebo at all doses, with robust effect sizes and improvements in cognition.

  • Phase 3 SCZ trial is planned for initiation in 1Q 2026, with topline data expected in 2H 2027; a Phase 2 BPD trial is also planned with topline data anticipated in 1Q 2028.

  • FDA feedback suggests potential for SCZ approval with one successful Phase 3 trial, streamlining the regulatory path.

  • Additional opportunities for indication expansion into MDD and development of long-acting injectable (LAI) formulations.

Efficacy and safety profile

  • LB-102 demonstrated clinically meaningful PANSS reductions and significant cognitive improvements in SCZ patients.

  • Safety profile is differentiated by low rates of extrapyramidal symptoms (EPS), negligible sedation, and minimal QTc prolongation.

  • Most adverse events were mild or moderate, with low rates of discontinuation and serious adverse events.

  • Weight gain was modest and no concerning metabolic signals were observed.

  • LB-102 retains the binding profile of amisulpride with improved blood-brain barrier permeability and potency.

Market opportunity and competitive landscape

  • Multibillion-dollar sales potential for LB-102 across SCZ, BPD, and MDD, with strong IP protection expected through 2041.

  • Branded antipsychotics in the U.S. generated ~$12B in 2024, with Vraylar, Abilify, Rexulti, and Caplyta accounting for ~60% of sales.

  • BPD and MDD represent large, underserved markets with substantial unmet needs for better efficacy, safety, and cognitive outcomes.

  • LB-102's differentiated profile positions it as a potential class leader, especially as few branded agents are expected at BPD launch.

  • Development path validated by successful precedents such as Vraylar and Caplyta.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage